Gynecologic cancer clinical practice guidelines in Korea and current issues

키워드

참고문헌 (14)

1. 홍세리, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017", Cancer Research and Treatment, 52(2), pp.335~350 (2020), 대한암학회
2. 하형인, "The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry", Obstetrics & Gynecology Science, 64(5), pp.444~453 (2021), 대한산부인과학회
3. 서동훈, "Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement", Journal of Gynecologic Oncology, 29(4), pp.1~18 (2018), 대한부인종양학회[DOI]
4. Claudia Marchetti, "Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers", BMC Women's Health, 14(1), pp.150~ (2014), Springer Science and Business Media LLC[DOI]
5. Tatsuyuki Chiyoda, "Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis", Journal of Gynecologic Oncology, 31(5), pp.1~13 (2020), 대한부인종양학회[DOI]
6. Sarah L Coleridge, "Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer", Cochrane Database of Systematic Reviews, 2(2), pp.CD005343~ (2021), Wiley[DOI]
7. Willemien J. van Driel, "Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer", New England Journal of Medicine, 378(3), pp.230~240 (2018), Massachusetts Medical Society[DOI]
8. Eric Pujade-Lauraine, "Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1", 2 mutation (SOLO2, The Lancet Oncology, pp.2017, 18(9)[DOI]
9. Andrés Poveda, "Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1", 2 mutation (SOLO2, The Lancet Oncology, pp.2021, 22(5)[DOI]
10. "PARP inhibitors get insurance benefits for 1st-line maintenance in ovarian cancer" (2021)[URL]
11. 이신화, "Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement", Journal of Gynecologic Oncology, 28(1), pp.1~22 (2017), 대한부인종양학회[DOI]
12. Kimberly D. Miller, "Cancer treatment and survivorship statistics, 2016", CA: A Cancer Journal for Clinicians, 66(4), pp.271~289 (2016), Wiley[DOI]
13. Pedro T. Ramirez, "Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer", New England Journal of Medicine, 379(20), pp.1895~1904 (2018), Massachusetts Medical Society[DOI]
14. Krishnansu S. Tewari, "Improved Survival with Bevacizumab in Advanced Cervical Cancer", New England Journal of Medicine, 370(8), pp.734~743 (2014), Massachusetts Medical Society[DOI]

관련 논문AI추천